Search

Your search keyword '"Duvall, George"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Duvall, George" Remove constraint Author: "Duvall, George"
90 results on '"Duvall, George"'

Search Results

1. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

2. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

3. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

4. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

5. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

6. Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

7. Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

8. Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

9. S907 Guselkumab Improves Abdominal Pain and Bowel Urgency Symptoms in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study

10. 111 - EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U- EXCEL STUDY

11. S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results From a Randomized Phase 3 U-EXCEL Study

12. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial

13. 867f: EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO FAILED PRIOR BIOLOGICS: RESULTS FROM A RANDOMIZED PHASE 3 U-EXCEED STUDY

14. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

15. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials

29. Entropic Equations of State and Their Application to Shock Wave Phenomena in Solids.

33. Letters.

34. Electronic Spectra of Various Liquids under Shock Conditions.

35. Shock Compression of Bimetallic Junctions

36. Optical Spectroscopy of Dynamically Compressed Liquids.

37. Shock-Induced Chemical Reactions in Condensed Matter.

38. Shock-Induced Reaction in Carbon Disulfide.

39. Shock-Induced Martensite Reversal in Fe/30%Ni.

40. Shock-Induced Decomposition of Carbon Disulfide.

41. Shock-Induced Decomposition of Carbon Disulfide.

42. Electrical Response of a Bimetallic Junction to Shock Compression.

43. Failure Properties of Aluminum and Aluminum Alloys under Impact Conditions.

45. WASTE HEAT IN LIQUID SPHERICAL BURSTERS

46. Theory of Equations of State: Elastic-Plastic Effects 2

47. Shock Waves in Solids

48. Kinetics of Shock-Induced Phase Transitions.

49. Some Experimental Manifestations of Instabilities in Shock Waves

50. Equation of State of Solids.

Catalog

Books, media, physical & digital resources